Ariz. Admin. Code § R9-6-319 - Carbapenem-resistant Pseudomonas aeruginosa
A. Case control measures:
1. A diagnosing health care provider or an
administrator of a health care institution, either personally or through a
representative, shall:
a. Institute isolation
precautions as necessary for a case with carbapenem-resistant
Pseudomonas aeruginosa infection or colonization to prevent
transmission; and
b. If a case with
carbapenem-resistant Pseudomonas aeruginosa infection or
colonization is being transferred to another health care provider or health
care institution or to a correctional facility, comply with
R9-6-305.
2. An administrator of a correctional
facility, either personally or through a representative, shall:
a. Institute isolation precautions as
necessary for a case with carbapenem-resistant Pseudomonas
aeruginosa infection or colonization to prevent transmission;
and
b. If a case with
carbapenem-resistant Pseudomonas aeruginosa infection or
colonization is being transferred to another correctional facility or to a
health care institution, comply with R9-6-305.
3. A local health agency, in consultation
with the Department, shall ensure that:
a. A
case with carbapenem-resistant Pseudomonas aeruginosa
infection or colonization is isolated as necessary to prevent transmission;
and
b. An isolate or a specimen, as
available, from each case with carbapenem-resistant Pseudomonas
aeruginosa infection or colonization is submitted to the Arizona State
Laboratory.
B.
Outbreak control measures: A local health agency shall:
1. Conduct an epidemiologic investigation for
each outbreak or suspected outbreak of carbapenem-resistant Pseudomonas
aeruginosa; and
2. For
each outbreak or suspected outbreak of carbapenem-resistant Pseudomonas
aeruginosa, submit to the Department the information required under
R9-6-206(E).
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
A. Case control measures:
1. The Department shall review each chlamydia infection case report for completeness, accuracy, and need for
2. A local health agency shall comply with the requirements specified in R9-6-1103 concerning treatment and health education for a Chlamydia trachomatis infection case that seeks treatment from the local health agency.
B. Contact control measures: If an individual who may have been exposed to chlamydia through sexual contact with a Chlamydia trachomatis infection case seeks treatment for symptoms of chlamydia infection from a local health agency, the local health agency shall comply with the requirements specified in R9-6-1103 concerning treatment and health education for the individual.